Autopsy report · NCT04348474
Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19
Cause of deathFunding or business
“Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this study.”
Life of this trial
- Suspended: paused, and may or may not restart.
- 200 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Early Phase 1
- Sponsor
- Azidus Brasil
- Sponsor type
- Industry
- Conditions
- Covid-19
- Interventions
- Hydroxychloroquine Sulfate; Azithromycin Tablets
- Participants
- 200 (planned, not actual)
- Sites
- 1
- Countries
- Brazil
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.